ProUroCare Medical Inc. (PUMD)

Market Cap	3.72K
Revenue (ttm)	n/a
Net Income (ttm)	-2.11M
Shares Out	18.60M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	5,020
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0002
Beta	9.20
RSI	n/a
Earnings Date	n/a

About ProUroCare Medical

ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: PUMD